ArticleAnnals of medicine and surgery (2012)2026
Laron syndrome presenting with severe low bone density for age in a 28-year-old woman: a case report.
Article in Annals of medicine and surgery (2012), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Laron syndrome (LS) is a rare, autosomal recessive disorder of growth hormone insensitivity, characterized by proportional short stature and low concentrations of insulin-like growth factor-1 (IGF-1) despite normal or increased levels of growth hormone. Case presentation: A 28-year-old woman presented with proportional short stature and a markedly low body weight, with a BMI of 14.5 kg/m Clinical discussion: Based on the phenotypic presentation and endocrine profile of the patient, a clinical diagnosis of LS was formulated. Unlike common LS presentations, this patient was markedly underweight, suggesting ethnic and nutritional variations. The comorbid vitamin D deficiency likely acted as a disease modifier, exacerbating the skeletal complications in an already compromised skeletal system. Conclusion: This case underscores the importance of strong clinical acumen in diagnosing rare growth disorders, especially in resource-limited settings where confirmatory genetic testing is not readily available. It also highlights how secondary bone disturbances can exacerbate the presentation, leading to significant functional impairment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.